Chemoinformaics analysis of Gzvmbxdquqrict-usognsfasa-
| Molecular Weight | 858.972 | nRot | 10 |
| Heavy Atom Molecular Weight | 792.444 | nRig | 43 |
| Exact Molecular Weight | 858.425 | nRing | 8 |
| Solubility: LogS | -2.817 | nHRing | 4 |
| Solubility: LogP | 1.369 | No. of Aliphatic Rings | 8 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
| Atoms Count | 126 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 60 | No. of Aromatic Carbocycles | 0 |
| nHetero | 18 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 4 |
| No. of Hydrogen atom | 66 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 42 | No. of Saturated Rings | 7 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 18 | No. of Arom Bond | 0 |
| nHA | 18 | APOL | 128.584 |
| nHD | 9 | BPOL | 80.9677 |
| QED | 0.136 |
| Synth | 6.176 |
| Natural Product Likeliness | 2.146 |
| NR-PPAR-gamma | 0.29 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.988 |
| HIA | 0.995 |
| CACO-2 | -6.529 |
| MDCK | 0.0000964 |
| BBB | 0.056 |
| PPB | 0.840815 |
| VDSS | 0.043 |
| FU | 0.108257 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.452 |
| CYP2c19-inh | 0.002 |
| CYP2c19-sub | 0.077 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.006 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.08 |
| CYP3a4-inh | 0.032 |
| CYP3a4-sub | 0.028 |
| CL | 0.553 |
| T12 | 0.775 |
| hERG | 0.5 |
| Ames | 0.081 |
| ROA | 0.393 |
| SkinSen | 0.935 |
| Carcinogencity | 0.056 |
| EI | 0.007 |
| Respiratory | 0.966 |
| NR-Aromatase | 0.844 |
| Antiviral | Yes |
| Prediction | 0.854443 |